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Abstract 
G-protein coupled receptors interact to provide additional regulatory mechanisms for 
neurotransmitter signaling. Adenosine A2A receptors are expressed at a high density in 
striatal neurons, where they closely interact with dopamine D2 receptors and modulate 
effects of dopamine and responses to psychostimulants. A2A receptors are expressed at 
much lower densities in other forebrain neurons but play a more prominent yet 
opposing role to striatal receptors in response to psychostimulants in mice. It is, 
therefore, possible that A2A receptors expressed at low levels elsewhere in the brain 
may also regulate neurotransmitter systems and modulate neuronal functions. 
Dopamine D2 receptors play an important role in autoinhibition of neuronal firing in 
dopamine neurons of the ventral tegmental area (VTA) and dopamine release in other 
brain areas. Here, we examined the effect of A2A receptor deletion on D2 receptor-
mediated inhibition of neuronal firing in dopamine neurons in the VTA. Spontaneous 
activity of dopamine neurons was recorded in midbrain slices, and concentration-
dependent effects of the dopamine D2 receptor agonist, quinpirole, was compared 
between wild-type and A2A knockout mice. The potency of quinpirole applied in 
single concentrations and the expression of D2 receptors were not altered in the VTA 
of the knockout mice.  However, quinpirole applied in stepwise escalating 
concentrations caused significantly reduced maximal inhibition in A2A knockout mice, 
indicating an enhanced agonist-induced desensitization of D2 receptors in the absence 
of A2A receptors. The A2A receptor agonist, CGS21680, did not exert any effect on 
dopamine neuron firing or response to quinpirole, revealing a novel non-
pharmacological interaction between adenosine A2A receptors and dopaminergic 
neurotransmission in midbrain dopamine neurons. Altered D2 receptor desensitisation 
may result in changes in dopamine neuron firing rate and pattern and dopamine 
3 
 
release in other brain areas in response to persistent dopamine release and 
administration of psychostimulants. 
 
Keywords. adenosine A2A receptor, dopamine D2 receptor, dopamine neuron, D2 
receptor desensitization, A2A receptor knockout mice, ventral tegmental area 
Abbreviations.  
CGS21680,  4-[2-[[6-amino-9-[(N-ethyl-β-D-ribofuranuronamidosyl)-9H-purin-2-
yl]amino]ethyl]benzene propanoic acid hydrochloride 
SCH23390,  (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-
3-benzazepine hydrochloride 
VTA,   ventral tegmental area 
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Introduction 
Increasing numbers of studies show that G-protein coupled receptor (GPCR) signaling 
can occur through the formation of oligo-dimers or multimers in neurons (Dalrymple 
et al., 2008; Ferre et al., 2008). Adenosine A2A receptors are Gs/olf-coupled receptors 
for the endogenous neuromodulator adenosine (Fredholm et al., 2011). The 
expression of A2A receptors in the brain is at the highest density in the soma of the 
GABAergic medium spiny neurons in the striatum, with significantly lower levels of 
expression elsewhere in the brain (Rosin et al., 1998; Svenningsson et al., 1999; 
Rosin et al., 2003). In the striatum, A2A receptors co-localize with dopamine D2 
receptors (Ferre et al., 2008). Via different G-protein coupling and second messenger 
systems, the activation of the adenosine A2A receptors increases cAMP levels and 
cellular excitability, while the activation of the dopamine D2 receptors decreases 
cAMP levels and cellular excitability. Antagonistic interactions between the two 
receptor systems are also manifested by direct receptor-receptor cross-talk in the form 
of heterodimers, where stimulation of the adenosine A2A receptors causes a reduction 
in the affinity of dopamine D2 receptor agonists and vice versa (Ferre et al., 1991; 
Kull et al., 1999; Azdad et al., 2009). The functional interactions between adenosine 
A2A receptors and dopamine D2 receptors are thought to underlie the involvement of 
adenosine A2A receptors in the control of several behavioral functions (Sebastiao & 
Ribeiro, 1996; Fredholm et al., 2005). Most notably, A2A receptor agonists inhibit the 
motor and rewarding effects of psychostimulants, similar to effects produced by 
dopamine D2 receptor antagonists; whereas A2A receptor antagonists potentiate effects 
of psychostimulants, in agreement with the activation of dopamine D2 receptors 
(Rimondini et al., 1997; Shimazoe et al., 2000; Knapp et al., 2001; Filip et al., 2006).  
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In adenosine A2A receptor knockout mice (Ledent et al., 1997), however, both the 
motor and reward effects of psychostimulants were reduced (Chen et al., 2000; 
Fredholm et al., 2005; Soria et al., 2005; Castane et al., 2006; Soria et al., 2006; Shen 
et al., 2008), contrary to the enhancing effects of  A2A receptor antagonists in wild-
type mice. The discord between effects of A2A receptor ligands and genetic silencing 
raises potential issues regarding the long-term use of A2A receptor antagonists for the 
treatment of Parkinson’s disease (Schwarzschild et al., 2006) and A2A agonists for 
schizophrenia (Ferre, 1997). Compensatory alterations in neural circuits are one of the 
possible causes for the different effects of psychostimulants in the A2A receptor 
knockout mice. However,  extrastriatal A2A receptors, for example those located on 
glutamatergic inputs to the striatum from the cerebral cortex (Schiffmann et al., 
2007), albeit at low expression density, were found to mediate a prominent excitatory 
effects of psychostimulants, opposite to the effects of postsynaptic striatal A2A 
receptors on striatopallidal neurons (Shen et al., 2008). The use of striatum and 
forebrain-specific A2A receptor knockout mice has revealed that extrastriatal A2A 
receptors in the forebrain predominently mediate the excitatory effects of 
psychostimulants, while striatal A2A receptors mediate inhibitory effects of 
psychostimulants (Shen et al., 2008). These findings may suggest that A2A receptors 
that are expressed outside the striatum, albeit at low densities, could play significant 
roles in neuronal functions. 
 
The ventral tegmental area (VTA) is a midbrain region closely involved in 
dopaminergic neurotransmission, as dopaminergic neurons in the VTA form 
ascending mesocorticolimbic projections to forebrain regions. In addition, the VTA is 
suggested to be the site important for the development of sensitization to repeated 
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exposures to drugs of abuse, via effects of dopamine on dopamine receptors (Wise, 
1996) and neuroplastic changes at glutamatergic synapses  (Bonci & Malenka, 1999). 
Dopamine D1- and D2-like receptors (referred to as D1 and D2 receptors thereafter) are 
highly expressed in the VTA (Bouthenet et al., 1987; Wamsley et al., 1989; Chen et 
al., 1991; Adell & Artigas, 2004), where activation of D2 receptors inhibits the firing 
activity of dopamine neurons, carrying out an important autoinhibitory function 
(Bunney et al., 1973; White & Wang, 1984; Sibley et al., 1993; Mercuri et al., 1997; 
Adell & Artigas, 2004).  
 
We examined the effects of A2A receptor deletion on D2 receptor-mediated 
autoinhibition of VTA dopamine neuron firing activity in brain slices. Concentration-
dependent effects of the D2 receptor-selective agonist, quinpirole, were investigated in 
wild-type and the global adenosine A2A receptor knockout mice. Expression of 
dopamine receptors in the VTA of the A2A knockout mice and effects of the A2A 
receptor agonist CGS21680 on neuronal firing and responses to quinpirole were also 
assessed. We found that the maximal effect of quinpirole was reduced in the A2A 
receptor knockout mice when treated with rising concentrations of quinpirole, but not 
single concentrations, which may indicate enhanced agonist-induced desensitization 
of D2 receptors in the absence of A2A receptors. A novel role of A2A receptors in 
modulating dopaminergic neurotransmission is revealed. 
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Experimental Procedures 
All animal breeding and experiments were conducted in accordance with the UK 
Animals (Scientific Procedures) Act 1986. 
 
VTA slice preparation and electrophysiological recordings 
The adenosine A2A receptor knockout mice on the out-bred CD1 background were 
originally created by Ledent et al. (1997) and heterozygous breeding colonies are 
maintained at the University of Surrey. Midbrain slices were prepared from wildtype 
and adenosine A2A receptor knockout mice aged 3-4 weeks. The mice were killed by 
cervical dislocation and the whole brains were immediately dissected and immersed in 
ice cold sucrose-containing buffer and saturated with 95% O2/5% CO2. The sucrose-
containing buffer contained: 200 mM sucrose, 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 25 mM NaHCO3, 10 mM MgSO4, 2.5 mM 
KCl, 1.2 mM NaH2PO4 and 0.5 mM CaCl2. The midbrain block was dissected and 
mounted with cyanoacrylic glue to a glass cutting stage of a vibratome (Series 1000 
Vibratome, St. Louis, Missouri, USA). Single coronal sections (300 μm) containing 
the VTA were harvested (3-4 per animal) and placed in an incubation chamber for at 
least 1 hour at 27-28˚C in oxygenated aCSF, which contained NaCl 123 mM, 
NaHCO3 22 mM, NaH2PO4 1.25 mM, KCl 3.75 mM, D-Glucose 10 mM, CaCl2 2.5 
mM and MgSO4 1.2 mM.  
 
Electrophysiological recordings were performed as previously detailed for rat VTA 
slice preparations (Chen et al., 2005; de Filippi et al., 2010). A single slice was placed 
in the recording chamber and continuously perfused with oxygenated aCSF at a flow 
rate of 2 ml/min and at 32 ± 0.5°C. The VTA area was identified as a grey area medial 
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to the substantia nigra and the medial lemniscus. Borosilicate glass microelectrodes 
with a tip of approximately 1 μm, pulled with a P-97 Flaming/Brown micropipette 
puller (Sutter Instrument Company, Novato, California, USA), were filled with aCSF 
to give an impedance of 3-6 MΩ and used for recording from single neurons. 
Extracellular recordings of the spontaneous action potentials were amplified 
(AxonPatch 1D, Molecular Devices Corp., Silicon Valley, CA, USA) initially by  10 
times in the I = 0 mode with a low-cut off frequency at 5 kHz and then by 100 times 
in the AC mode (Neurolog systems, Digitimer, Welwyn Garden City, UK)  without 
any further filtering. Signals were digitised using CED1401 Micro Mark 2 
(Cambridge Electronic Design Ltd, Cambridge, UK), and captured with Spike 2 
Software Version 5.2 (Cambridge Electronic Design Ltd, Cambridge, UK).  
 
Two types of spontaneously firing neurons in the VTA were recorded and identified. 
Dopamine neurons were classically defined by their pacemaker-like spontaneous 
firing, with frequencies at 0.5 to 4 Hz and an action potential waveform of 2.5 – 3 ms 
in duration with a large negative phase. The firing frequency was significantly 
suppressed by 50 µM dopamine (-74.2 ± 4.8%, n = 29) or by the D2 agonist, 
quinpirole (Grace & Onn, 1989; Johnson & North, 1992). The other type of neurons 
displayed higher spontaneous firing frequencies (4 – 15 Hz) with action potential 
waveforms of a shorter duration (~ 2ms). Dopamine did not inhibit the firing of these 
classically defined non-dopaminergic or GABAergic neurons (Grace & Onn, 1989; 
Johnson & North, 1992). A recent study confirmed that almost all 
electrophysiologically-classified dopaminergic neurons are tyrosine hydroxylase-
positive (Brown et al., 2009), despite discrepancies found in some other studies 
(Margolis et al., 2006; Margolis et al., 2010). “Dopamine neurones” referred to in this 
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study are therefore those that conform to electrophysiological and pharmacological 
criteria, but not necessarily to the content of dopamine. 
 
Autoradiographic binding 
The brains of wild-type and adenosine A2A receptor knockout mice were removed, 
snap frozen in isopentane (-35˚C) and stored at -80˚C until sectioning. Adjacent 20 
μm coronal sections were cut at an interval of 300 μm for the determination of total 
and non-specific binding (NSB). Quantitative autoradiography was performed as 
detailed previously for dopamine D1 and D2 receptor binding (Lena et al., 2004) and 
dopamine transporters (Javitch et al., 1985; Bailey et al., 2007) using [3H]SCH23390, 
[3H]raclopride and [3H]mazindol, respectively. The ligand concentration (4 nM) was 
3-4 times Kd. Non-specific binding (NSB) was defined in the presence of 10 μM cis-
flupenthixol for D1, sulpiride for D2 and non-tritiated mazindol for dopamine 
tranporter. Quantitative analysis of brain receptors was performed as detailed 
previously (Kitchen et al., 1997; Bailey et al., 2004b; Lena et al., 2004) using an 
MCID image analyser (ImageResearch, Canada).  
 
Statistical Analysis 
The mean and standard error of the mean were presented. Comparison of quantitative 
measures was carried out, where appropriate, using Student’s t-test or two-way 
ANOVA followed by a Newman Keuls post-hoc analysis. Only one slice was used 
from each mouse for each set of experiment, so that the n numbers given represent 
both the number of neurons and the number of mice. 
 
Materials 
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Quinpirole and CGS21680 were purchased from Tocris Bioscience (Bristol, Somerset, 
UK), and sulpiride and NECA were supplied by Sigma-Aldrich Company Ltd 
(Dorset, UK). [3H]raclopride (60.1 Ci/mmol), [3H]SCH23390 (85.0 Ci/mmol) and 
[3H]mazindol (17.8 Ci/mmol) were purchased from Perkin Elmer (Buckinghamshire, 
UK). The [3H] microscales were purchased from Amersham International 
(Buckinghamshire, UK). The autoradiographic film, developer and fixer were 
supplied by Sigma-Aldrich Company Ltd (Dorset, UK). 
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Results 
Potency of quinpirole on dopamine neuron firing is similar between wild-type and 
A2A receptor knockout mice 
To examine the function of dopamine D2 receptors in adenosine A2A receptor 
knockout mice, concentration-dependent effects of the D2 receptor agonist, quinpirole, 
were examined on dopamine neuron firing in midbrain slices. Bath application (15 
min) of single concentrations of quinpirole ranged between 1 nM and 1 µM inhibited 
dopamine neuron firing rate concentration-dependently, in agreement with previous 
reports (Bowery et al., 1994; Mercuri et al., 1997; Centonze et al., 2002). Complete 
inhibition was achieved in both wild-type (Fig. 1A, n = 4-7 per data point) and 
adenosine A2A receptor knockout mice (Fig. 1B, n = 3-5 per data point), and the EC50 
values were not different between the wild-type (11.7 nM or LogEC50 = -1.93 ± 0.15 
µM) and knockout mice (14.5 nM or LogEC50 = -1.84 ± 0.04 µM, P > 0.05, two-way 
ANOVA), showing the similar potencies of quinpirole on D2 receptors in dopamine 
neurons of A2A receptor knockout mice.  
 
In addition, the baseline firing frequency and the pacemaker firing pattern of 
dopamine neurons were also similar (P > 0.05; Student’s t-test) between wild-type 
(1.8 ± 0.2Hz, n = 22) and adenosine A2A receptor knockout mice (1.8 ± 0.3Hz, n = 
14). Action potential waveforms were also unchanged, indicating unaltered basic 
electrophysiological characteristics in dopamine neurons (data not shown). The D2 
receptor antagonist sulpiride (10 µM) blocked the effects of quinpirole in both 
genotypes without altering baseline firing rate (data not shown), confirming that the 
effect of quinpirole was mediated by D2 receptors (Bernardini et al., 1991; Bowery et 
al., 1994; Mercuri et al., 1997; Centonze et al., 2002), and that the baseline firing rate 
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of dopamine neurons in vitro was not affected by D2 receptors (Grace & Onn, 1989; 
Johnson & North, 1992). 
 
Reduced cumulative effect of quinpirole on dopamine neuron firing in A2A receptor 
knockout mice  
Although the effects of D2 receptor activation in response to single concentrations of 
quinpirole were not different between wild-type and A2A receptor knockout mice, 
rising concentrations of dopamine (Nimitvilai & Brodie, 2010), prolonged 
synchronous stimulation of dopamine neurons (Beckstead & Williams, 2007) and 
administration of cocaine (Di Chiara, 1995; Ford et al., 2010) may cause receptor 
desensitisation (Beckstead & Williams, 2007). To examine the effect of A2A receptor 
deletion on D2 receptor desensitisation, quinpirole was applied cumulatively in rapidly 
escalating concentrations (0.01 – 30 µM, 5 min at each concentration). The EC50 
value for quinpirole applied in this way was approximately 4 times higher than that at 
single concentrations (44.9 vs. 11.7 nM in wild-type mice), showing reduced 
sensitivity of D2 receptors probably due to agonist-induced receptor desensitisation. 
The EC50 values were again not different between wild-type and knockout mice (44.9 
nM or LogEC50 = -1.34 ± 0.05 µM vs. 44.9 nM or LogEC50 = -1.35 ± 0.13, Fig. 2). 
However, the maximal effects of quinpirole were different. In a majority of the wild-
type mice (n = 10/11), quinpirole induced complete inhibition of firing rate, similar to 
single concentration experiments; whereas in more than half of the A2A receptor 
knockout mice, the firing rates were only partially blocked by the D2 agonist (n = 4/7, 
Fig. 2B). As a result, the mean maximal response in the A2A receptor knockout mice 
(81.2% ± 4.8, n = 7, P < 0.05, Students’ t-test) was significantly reduced compared to 
the wild-type mice (96.5% ± 2.3, n = 11), showing a significantly greater reduction of 
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D2 receptor function in the absence of A2A receptors. The effects of quinpirole in both 
genotypes were prevented by sulpiride (10 µM, Fig. 2A), confirming D2 receptor-
mediated effects. The absence of A2A receptors, therefore, increased agonist-induced 
D2 receptor desensitisation in dopamine neurons. 
 
No change in the expression of dopamine D1 and D2 receptors and dopamine 
transporters in the A2A receptor knockout mice 
Although the potency of quinpirole was similar in both genotypes, it is unknown 
whether the expression of D2 receptors was changed in dopamine neurons of the A2A 
receptor knockout mice. Previous studies from our and other groups identified no 
change in D2 receptor densities in the striatal quadrant of the adenosine A2A receptor 
knockout brains despite significant increases in dopamine D1, D2 and DAT mRNAs 
(Chen et al., 2001; Dassesse et al., 2001; Bailey et al., 2004a; Short et al., 2006), but 
their expressions in the VTA were not examined. Here, we examined the expression 
of dopamine receptors in the midbrain regions by autoradiography.  
  
D2 receptor density was measured by [3H]raclopride binding in the VTA and 
substantia nigra (Fig. 3 lower panels), nucleus accumbens and caudate putamen (Fig. 
3 upper panels), as well as olfactory tubercle. Overall, the results show a lack of 
statistically significant differences in any single brain regions, including the VTA, in 
the knockout brain, despite a small but significant genotype effect overall (Table 1, P 
< 0.05, Two-way ANOVA). In addition, D1 receptor and dopamine transporter 
binding in any of the brain regions investigated were not significantly changed (Table 
1), indicating their unaltered expression levels. The unaltered D2 receptor expression 
in the VTA in A2A receptor knockout mice is in agreement with the similar potencies 
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of quinpirole found on firing rate inhibition, showing unchanged D2 receptors 
function in the VTA.   
 
The lack of functional A2A receptors in dopamine neurons of the VTA 
In order to understand how the deletion of A2A receptors affects D2 receptor function, 
we examined for any functional role of adenosine A2A receptors on dopamine neuron 
firing and on effects of quinpirole. The A2A receptor-selective agonist, CGS21680, 
applied for 10 min in the aCSF at concentrations of 0.001, 0.01, 0.1, 1, 10 and 30 µM, 
caused no significant effects on baseline firing frequency or pattern in the wild-type 
mice (P > 0.05, Student’s paired t-test, n = 2-4 for each concentration, data not 
shown), showing a lack of direct effect of A2A receptor activation on dopamine 
neurons.  
 
Effects of CGS21680 (1 µM, 10 min pre-treatment) on quinpirole-induced firing rate 
inhibition were also examined in the wild-type mice. No significant difference was 
seen on the effects of 30 nM quinpirole, a submaximal concentration, with 64.8 ± 
13.2% inhibition before and 64.9 ± 19.3% after the treatment with CGS21680 (n = 5, 
P > 0.05, paired t-test). Direct pharmacological interactions between A2A and D2 
receptors were, therefore, not detected on dopamine neurons. 
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Discussion 
The results show a decreased use-dependent function of dopamine D2 receptors in 
midbrain dopamine neurons in the absence of adenosine A2A receptors. The dopamine 
D2 receptor agonist quinpirole exhibited similar potencies on the inhibition of 
dopamine neuron firing rate between wild-type and adenosine A2A knockout mice 
when applied at single concentrations, with D2 receptor binding not significantly 
altered in the VTA. However, the maximum effect of quinpirole, when applied 
cumulatively at increasing concentrations, was reduced to a greater extent in the 
adenosine A2A receptor knockout mice, indicating increased agonist-induced D2 
receptor desensitisation in the absence of A2A receptors. As D2 receptors serve an 
important autoinhibitory role in the regulation of dopamine neuron firing, reduction of 
D2 receptor function could affect firing rate and pattern of dopamine neurons in a use-
dependent manner and alter action potential-dependent dopamine release in other 
brain areas in vivo.  
 
Activation of D2 receptors stimulates G-proteins (Gi/o) leading to opening of G-
protein–coupled inward rectifying potassium (GIRK) channels, which hyperpolarises 
the membrane potential and reduces the firing rate of dopamine neurons (Grace & 
Onn, 1989). The efficacy of agonist-induced reduction of dopamine neuron firing rate 
can, therefore, be modulated by several mechanisms. One way is through reduction in 
receptor availability, by reducing receptor expression or accelerating receptor 
internalisation, which involves endocytosis of agonist-bound receptors via 
phosphorylation by G-protein receptor kinases and binding with β-arrestin 
(Hanyaloglu & von Zastrow, 2008). Other mechanisms may involve changes in G-
protein availability, G-protein coupling to GIRK channels, and the availability and 
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activity of GIRK channels (Werner et al., 1996). As the effects of quinpirole tested in 
single concentrations were not different between wild-type and A2A receptors 
knockout mice (Fig. 1), and there was no change in the total number of receptors 
under normal conditions (Table 1), D2 receptor availability and coupling to effectors 
were probably unaltered. The reduced maximal effect of accumulative quinpirole in 
A2A receptors knockout mice (Fig. 2) was, therefore, most likely caused by increased 
receptor desensitisation with the hallmark of use-dependency (Hanyaloglu & von 
Zastrow, 2008). 
 
D2 receptor desensitisation is not normally apparent when agonists are used to inhibit 
dopamine neuron firing in vitro (Fig. 1) (Bowery et al., 1994; Mercuri et al., 1997; 
Centonze et al., 2002) or in vivo (Bunney et al., 1973; White & Wang, 1984; Kalivas 
et al., 1993; Sibley et al., 1993; Adell & Artigas, 2004), in agreement with their role 
of providing essential feedback autoinhibition on dopamine neurons. However, 
desensitisation can be induced with high concentrations of agonists (Beckstead & 
Williams, 2007), in particular with accumulative dosing (Fig. 2) (Nimitvilai & Brodie, 
2010), showing agonist and concentration-dependency of receptor internalisation. 
Furthermore, desensitization of D2 receptors in the VTA was enhanced by concurrent 
activation of D1/D5 receptors (Nimitvilai & Brodie, 2010), indicating modulation by 
other receptors. Here, we show that deletion of adenosine A2A receptors enhances D2 
receptor desensitization induced by accumulative dosing of quinpirole in the VTA, 
indicating interaction between the two receptors on D2 receptor trafficking 
(Hanyaloglu & von Zastrow, 2008). 
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A2A receptors are known to have high affinities for D2 receptors (Ferre et al., 2008) 
and their heterodimers also have the potential to internalise differentially from each 
homomers and, thereby, desensitise differentially (Hillion et al., 2002; Torvinen et al., 
2005; Vidi et al., 2008). We also show here that the A2A receptor agonist, CGS21680, 
did not cause any pharmacological effect on the firing rate or pattern of dopamine 
neurons, confirming the lack of pharmacologically accessible A2A receptors on 
dopamine neurons, which is in agreement with a low level of A2A receptor expression 
in the VTA (Rosin et al., 1998; Rosin et al., 2003). CGS21680 also failed to acutely 
alter D2 receptor function in the VTA, indicating a lack of direct pharmacological 
interaction between D2 and A2A receptors in the VTA, like those in the striatum 
(Azdad et al., 2009).  
 
One possible explanation for the results is that A2A receptors are not expressed as 
functional receptors in dopamine neurons but participate in D2 receptor trafficking. 
Although GPCR heterodimerisation tends to cause cross-conformational switch 
resulting in changes in receptor affinity for pharmacological ligands (Dalrymple et al., 
2008; Ferre et al., 2008), a recent study showed that the association of GABAB2 with 
muscarinic M2 receptors selectively prevented M2 receptor internalization in PC12 
cells without altering the dose-response of M2 receptor agonists (Boyer et al., 2009). 
Based on this model, it is therefore possible to speculate that A2A receptors may 
interface between D2 receptors and G-protein-coupled receptor-associated sorting 
proteins (Bartlett et al., 2005) to facilitate membrane insertion of D2 receptors. Indeed 
in the A2A receptor knockout mice, D2 receptor expression at the mRNA level were 
found increased, but not the number of functional receptors (Chen et al., 2001; 
Dassesse et al., 2001; Bailey et al., 2004a; Short et al., 2006). This scenario could be 
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explained by the presence of a larger proportion of internalised D2 receptors in the 
absence of A2A receptors.  
 
On the other hand, interaction between forebrain A2A receptors and VTA neuronal 
activity may also occur via neural network connections. Dopamine neurons in the 
VTA project to nucleus accumbens and the prefrontal cortex and these target areas 
also innervate the VTA via GABAergic and glutamatergic feedback loops, 
respectively (Kalivas et al., 1993; Pierce & Kumaresan, 2006). High density 
expression of A2A receptors is found in the nucleus accumbens. Although A2A 
receptors are predominantly expressed in association with D2 receptors in GABAergic 
enkephalinergic neurons, not the dynorphinergic neurons that form the GABAergic 
accumbens-mesencephic projections (Fenu et al., 1997; Lu et al., 1997; Svenningsson 
et al., 1999), deletion of A2A receptors in the nucleus accumbens may still indirectly 
affect the activities of dopamine neurons in the VTA. On glutamatergic terminals, A2A 
receptors were shown to modulate glutamate release in the striatum (Schiffmann et 
al., 2007) and mediate a prominent excitatory effect of psychostimulants (Shen et al., 
2008). It is unknown whether A2A receptors are expressed on glutamatergic terminals 
in the VTA, but a recent study indicated a role for forebrain A2A receptors in the 
VTA, as deletion of forebrain A2A receptors promoted survival of midbrain dopamine 
neurons in response to MPTP toxicity in mice (Carta et al., 2009). Assuming the 
existence of presynaptic A2A receptors on glutamatergic terminals in the VTA, their 
presynaptic modulation of glutamate release may alter the strength of glutamatergic 
synaptic transmission (Mansvelder & McGehee, 2000) and the activity state of 
dopamine neurons, which may subsequently regulate D2 receptor trafficking. 
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Whatever the mechanism underlying interaction between D2 and A2A receptors in 
dopamine neurons, reduced D2 receptor-mediated autoregulation of dopamine neuron 
activity in the VTA may contribute significantly to the dopaminergic state in A2A 
receptor knockout mice (Chen et al., 2000; Fredholm et al., 2005; Soria et al., 2005; 
Castane et al., 2006; Soria et al., 2006; Shen et al., 2008). D2 receptors are not  
activated during rhythmic single spike firing in vitro (Grace & Onn, 1989), but 
significantly contribute to burst firing of action potentials in vivo together with the 
intrinsic ion channel properties of dopamine neurons (Grace & Bunney, 1984) and 
excitatory inputs from other brain areas, with the activation of glutamatergic N-
methyl-D-aspartate receptors being most prominent (Overton & Clark, 1997). 
Synchronized high-frequency stimulation of dopamine neurons can activate D2 
receptors by increasing somatodendritic release of dopamine (Bunney et al., 1973; 
White & Wang, 1984; Sibley et al., 1993; Mercuri et al., 1997; Adell & Artigas, 
2004), with the resultant inhibitory current inhibits the firing of dopamine neurons 
generating a “pause” of firing (Beckstead et al., 2004). The presence of D2 receptor 
antagonist haloperidol, therefore, impaired burst by inducing depolarization block of 
firing (Grace & Bunney, 1986). Consequently, the release of dopamine in the striatum 
was reduced (Moore et al., 1998), further demonstrating the role of D2 receptors in 
homeostatic regulation of dopamine neuron activity and the release of dopamine in 
the nucleus accumbens and prefrontal cortex that mediate many of the behavioural 
consequences of dopamine release, particularly in response to reward (Schultz, 2002).  
 
Increased D2 receptor desensitisation also reduces autoinhibition in dopamine neurons, 
which could, subsequently affect the generation of burst activity. Consequently, 
dopamine release in other brain regions may be reduced, causing a hypodopaminergic 
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state reported previously in A2A receptor knockout mice (Chen et al., 2000; Fredholm 
et al., 2005; Soria et al., 2005; Castane et al., 2006; Soria et al., 2006; Shen et al., 
2008).  
 
Conclusions 
Increased dopamine D2 receptor desensitisation is revealed in dopamine neurons of 
the VTA in A2A receptor knockout mice, revealing a novel interaction between 
dopamine D2 and adenosine A2A receptors outside the striatum. The reduced D2 
receptor function may contribute to the hypodopaminergic state reported in A2A 
receptor knockout mice due to reduced D2 receptor-mediated regulation of dopamine 
neuron activity and subsequent dopamine release. Understanding A2A and D2 receptor 
interaction in midbrain dopamine neurons may shed new light on the roles of A2A 
receptors in dopamine related neurological and psychiatric disorders, such as drug 
addiction, schizophrenia and Parkinson’s disease, and on treatment strategies targeting 
the A2A receptors . 
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Figure legend 
 
Figure 1. Quinpirole, a dopamine D  receptor agonist, causes concentration-
dependent inhibition of the spontaneous firing rate of putative dopamine 
neurons in the VTA. Representative traces illustrate the similar effects of 0.1 µM 
quinpirole on the firing rate of dopamine neurons recorded in brain slices prepared 
from wild-type (A. WT) and A  receptor knockout mice (B. KO). 
2
2A Firing frequency 
(Hz) was calculated from 10s bins. C. The concentration-dependent inhibition of 
firing rate induced at different concentrations of quinpirole is compared between the 
WT and KO mice. There is no statistical significance between genotypes (P > 0.05, 
two-way ANOVA).  
 
Figure 2. Reduced inhibition of firing by quinpriole applied in cumulative 
concentrations in the A  receptor knockout mice. A. Quinpirole applied in 
escalating concentrations in a cumulative manner induced complete inhibition of the 
firing rate of dopamine neurons in the wild-type (WT), but the effect was reduced in 
the A  receptor knockout (KO) mice
2A
2A . The application of sulpiride (10 µM) blocked 
the effect of quinpirole. Firing frequency was calculated from 10s bins. B. A 
comparison of the accumulative concentration-dependent effects of quinpirole in WT 
(n = 11) and KO (n = 7) mice shows significantly reduced maximal effect in the KO 
mice (P < 0.05, two-way repeated measures ANOVA). 
 
 
Figure 3. Representative autoradiograms of dopamine D  receptor ligand 
[ H]raclopride in brain sections of wild-type (A. WT) and A  receptor knockout 
mice (B. A KO) show similar binding density. 
2
3
2A
2A Total binding was obtained using 4 
nM [ H]raclopride 3 at 3-4 times Kd. Non-specific binding (NSB) was defined in the 
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presence of 10 μM sulpiride. The colour bar shows the calibrated density of 
radioligand binding (fmol/mg) in black and white film images. Selective binding is 
obtained (see Table 1) by subtracting NSB from the total binding. Upper panels show 
coronal brain sections at the level of striatum and lower panels contain midbrain 
structures showing labelling in the ventral tegmental area and the substantia nigra. 
Sections from WT and KO mice were processed in parallel. 
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Fig. 2 
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Fig. 3 
 
 
fmol/mg
Table 1: Quantitative autoradiography of dopamine D2-like, D1-like receptors and dopamine transporters in brain regions of wild-type and 
adenosine A2A receptor knockout mice 
  
Dopamine D2 receptor 
 
 
Dopamine D1-like receptor 
 
 
Dopamine transporters 
 
Brain Regions 
WT 
(fmol/mg) 
A2A KO 
(fmol/mg) 
WT 
(fmol/mg) 
A2A KO 
(fmol/mg) 
WT 
(fmol/mg) 
A2A KO 
(fmol/mg) 
 
Nucleus 
accumbens  53.5 ± 4.2 60 ± 3.5 237.2 ± 15.8 248.1 ± 14.3 266.9 ± 20.2 200 ± 89.6 
Caudate 
putamen rostral 84.7 ± 6.5 91.6 ± 4.1 317.7 ± 10.8 347.7 ± 9.6 386.1 ± 18.9 312.7 ± 135.8 
Caudate 
putamen caudal 80.7 ± 10.3 97.7 ± 5.9 220.7 ± 10.8 250.7 ± 9.6 261.6 ± 14.9 220.8 ± 41.9 
Olfactory 
tubercle 50.4 ± 5.4 63.2 ± 9.0 253.6 ± 10.9 237.7 ± 17.1 277.1 ± 37.5 196.4 ± 77.1 
Substantia 
nigra 13.6 ± 4.2 17.3 ± 6.4 146.4 ± 17.2 134.3 ± 5.8 149.6 ± 15.6 120.8 ± 27.7 
Ventral 
tegmental area 7.6 ± 2.2 13.9 ± 5.2 12.5 ± 3.0 11.2 ± 2.0 187.7 ± 22.6 168.4 ± 20.0 
       
Sections were labeled with 4 nM [3H]raclopride (n=6), [3H]SCH23390 (n=6) and [3H]mazindol (n=4), for dopamine D2-like and D1-like 
receptors and transporters, respectively, in the wild-type (WT) and A2A receptor knockout (KO) mice.  Values are expressed as mean ± SEM. All 
structures were identified according to the brain atlas of Paxinos and Franklin (Paxinos & Franklin). Two-way ANOVA reveals significant 
genotype effect (P < 0.05) on overall D2 receptor binding, without any significant differences in any single region in posthoc test (P > 0.05). D1 
receptors or dopamine transporter densities were not different between genotypes (P > 0.05, two-way ANOVA). 
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